Christopher A. Siedlecki

Christopher A. Siedlecki

Auto-generated profile, based on publicly available information

Christopher A. Siedlecki

Department of Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, United States; Department of Biomedical Engineering, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, United States

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in Biomaterials
Verified
Journal Article
Closed access
LXLi-Chong Xu
Li-Chong Xu
CSChristopher A. Siedlecki
Christopher A. Siedlecki

1 December 2014 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
LXLi-Chong Xu
Li-Chong Xu
JBJames W. Bauer
James W. Bauer
CSChristopher A. Siedlecki
Christopher A. Siedlecki

26 February 2015 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
RMRhea M May
Rhea M May
CMChelsea M Magin
Chelsea M Magin
EMEthan E Mann
Ethan E Mann
MDMichael C Drinker
Michael C Drinker
JFJohn C Fraser
John C Fraser
SRShravanthi T Reddy
Shravanthi T Reddy
Background: Catheter‐related bloodstream infections (CRBSIs) and catheter‐related thrombosis (CRT) are common complications of central venous catheters (CVC), which are used to monitor patient health and deliver medications. CVCs are subject to protein adsorption and platelet adhesion as well as colonization by the natural skin flora (i.e. Staphylococcus aureus and Staphylococcus epidermidis). Antimicrobial and antithrombotic drugs can prevent infections and thrombosis‐related complications, but have associated resistance and safety risks. Surface topographies have shown promise in limiting platelet and bacterial adhesion, so it was hypothesized that an engineered Sharklet micropattern, inspired by shark‐skin, may provide a combined approach as it has wide reaching anti‐fouling capabilities. To assess the feasibility for this micropattern to improve CVC‐related healthcare outcomes, bacterial colonization and platelet interactions were analyzed in vitro on a material common for vascular access devices.Methods: To evaluate bacterial inhibition after simulated vascular exposure, micropatterned thermoplastic polyurethane surfaces were preconditioned with blood proteins in vitro then subjected to a bacterial challenge for 1 and 18 h. Platelet adhesion was assessed with fluorescent microscopy after incubation of the surfaces with platelet‐rich plasma (PRP) supplemented with calcium. Platelet activation was further assessed by monitoring fibrin formation with fluorescent microscopy after exposure of the surfaces to platelet‐rich plasma (PRP) supplemented with calcium in a flow‐cell. Results are reported as percent reductions and significance is based on t‐tests and ANOVA models of log reductions. All experiments were replicated at least three times.Results: Blood and serum conditioned micropatterned surfaces reduced 18 h S. aureus and S. epidermidis colonization by 70% (p ≤ 0.05) and 71% (p < 0.01), respectively, when compared to preconditioned unpatterned controls. Additionally, platelet adhesion and fibrin sheath formation were reduced by 86% and 80% (p < 0.05), respectively, on the micropattern, when compared to controls.Conclusions: The Sharklet micropattern, in a CVC‐relevant thermoplastic polyurethane, significantly reduced bacterial colonization and relevant platelet interactions after simulated vascular exposure. These results suggest that the incorporation of the Sharklet micropattern on the surface of a CVC may inhibit the initial events that lead to CRBSI and CRT.

8 November 2005 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
KMKeith R. Milner
Keith R. Milner
ASAlan J. Snyder
Alan J. Snyder
CSChristopher A. Siedlecki
Christopher A. Siedlecki

15 May 2017 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
YWYaqi Wo
Yaqi Wo
LXLi-Chong Xu
Li-Chong Xu
ZLZi Li
Zi Li
AMAdam J. Matzger
Adam J. Matzger
MMMark E. Meyerhoff
Mark E. Meyerhoff
CSChristopher A. Siedlecki
Christopher A. Siedlecki
A novel dual functioning antimicrobial CarboSil 20 80A polymer material that combines physical topographical surface modification and nitric oxide (NO) release is prepared and evaluated for its efficacy in reducing bacterial adhesion in vitro. The new biomaterial is created via a soft lithography two-stage replication process to induce submicron textures on its surface, followed by solvent impregnation with the NO donor, S-nitroso-N-acetylpenicillamine (SNAP), to obtain long-term (up to 38 d) NO release. The NO releasing textured polymer surface is evaluated against four bacteria commonly known to cause infections in hospital settings and the results demonstrate that the combined strategy enables a synergistic effect on reducing the bacterial adhesion of Staphylococcus epidermidis and Pseudomonas aeruginosa bacteria.

17 February 2009 in Langmuir
Verified
Journal Article
Closed access
LXLi-Chong Xu
Li-Chong Xu
CSChristopher A. Siedlecki
Christopher A. Siedlecki